A voucher program shaves months off of the FDA’s review process for drug development that targets rare pediatric diseases. more →
CREATING HOPE ACT AND PEDIATRIC PRIORITY REVIEW VOUCHERS NEWS
Everything you need to know about FDA’s Priority Review Vouchers (RAPS Regulatory Explainer)
What are the Priority Review Vouchers and how do they benefit the society? more →
The death of a child and a golden ticket for drug makers (STAT)
How did every parent’s worst nightmare — the death of a child — spur the creation of an incentive system to turn making drugs for childhood cancer from a high-risk, low-reward gamble to a bet a company might make? more →
Creating Hope Act reauthorized in 21st Century Cures (KVC Newsletter)
On December 13, 2016, President Obama signed into law the 21st Century Cures Act, reauthorizing the Creating Hope Act until 2020. more →
Congress passes CURES and reauthorizes The Creating Hope Act, 94-5!
December 7, 2016. Today, the U.S. Senate passed the 21st Century Cures Act and with it, reauthorization of the Creating Hope Act more →
The House reauthorized the Creating Hope Act
In a vote of 392 – 26, the House passed 21st Century Cures, which includes the Creating Hope Act Pediatric Priority Review more →
President Obama Signs the Advancing Hope Act to Extend the Creating Hope Act to December 31, 2016
We are proud to announce that on September 30, 2016 President Obama signed the Advancing Hope Act (S 1878) to extend the more →
Rare Disease Report: Representative McCaul Urges Reauthorization of Priority Review Voucher Program
By James Radke, PhD Last month, Congressman Michael McCaul spoke to the House of Representatives urging for the immediate reauthorization of more →
Kids v Cancer is #4 of Fast Company’s Top 10 most innovative companies in not-for-profit (KvC Press Release)
Fast Company praised Kids v Cancer for accelerating the discovery of pediatric cancer treatments. more →
Reauthorization of the Creating Hope Act (KvC Newsletter)
We aim to achieve permanent reauthorization, beyond the Omnibus’ new sunset of September 30, 2016, by supporting 21st Century Cures. more →
Kids v Cancer wins Peter Drucker award for nonprofit innovation (KvC Press Release)
Kids v Cancer was awarded the 2015 Peter F. Drucker Award for Nonprofit Innovation for its role in the 2012 Creating Hope Act. more →
Another Creating Hope Act voucher sold! (KvC Newsletter)
United Therapeutics Corporation announced the sale of its Creating Hope Act priority review voucher to AbbVie for $350 million. United Therapeutics earned the voucher for its development of Unituxin for neuroblastoma, a pediatric cancer. more →
Hope for children’s rare drug approval process (USA Today)
Advocates for children with rare diseases are watching closely a congressional effort to streamline the nation’s drug approval process. more →
Voucher sells for 245M!
Friends: Today, another Creating Hope Act pediatric priority review voucher sold for $245M! This voucher was sold to Sanofi by Retrophin. more →
Kids v Cancer Announces “The Advancing Hope Act” To Reauthorize The Pediatric Priority Review Voucher Program, April 21, 2015
Kids v Cancer Announces “The Advancing Hope Act” To Reauthorize The Pediatric Priority Review Voucher Program WASHINGTON, March 23, 2015 /PRNewswire-USNewswire/ — more →